(PDF) Immunogenicity of a Vaccine Formulated With the

Immunogenicity of a Vaccine Formulated With the Chlamydia Trachomatis Serovar F, Native Major Outer Membrane Protein in a Nonhuman Primate Model

Vaccine - Netherlands

doi 10.1016/j.vaccine.2011.02.057

Full Text

Open PDF

Abstract

Available in full text

Date

April 1, 2011

Authors

Publisher

Elsevier BV

Related search

Long-Term Stability of a Vaccine Formulated With the Amphipol-Trapped Major Outer Membrane Protein From Chlamydia Trachomatis

Journal of Membrane Biology

English

Protection Against an Intranasal Challenge by Vaccines Formulated With Native and Recombinant Preparations of the Chlamydia Trachomatis Major Outer Membrane Protein

English

Structural and Functional Analyses of the Major Outer Membrane Protein of Chlamydia Trachomatis

Journal of Bacteriology

Microbiology

Molecular Biology

2007

English

Mutagenesis of the P2 Promoter of the Major Outer Membrane Protein Gene of Chlamydia Trachomatis.

Journal of Bacteriology

Microbiology

Molecular Biology

1996

English

Immunization With the Chlamydia Trachomatis Mouse Pneumonitis Major Outer Membrane Protein Can Elicit a Protective Immune Response Against a Genital Challenge

Infection and Immunity

English

Failure to Detect Chlamydia Trachomatis in Cell Culture by Using a Monoclonal Antibody Directed Against the Major Outer Membrane Protein.

Journal of Clinical Microbiology

Microbiology

1997

English

A Vaccine Formulated With a Combination of TLR-2 and TLR-9 Adjuvants and the Recombinant Major Outer Membrane Protein Elicits a Robust Immune Response and Significant Protection Against a Chlamydia Muridarum Challenge

Microbes and Infection

English

The Role of Lipopolysaccharide in the Exposure of Protective Antigenic Sites on the Major Outer Membrane Protein of Chlamydia Trachomatis

Journal of General Microbiology

1992

English

Outer Membrane Proteins Preferentially Load MHC Class II Peptides: Implications for a Chlamydia Trachomatis T Cell Vaccine

English

Amanote Research

Immunogenicity of a Vaccine Formulated With the Chlamydia Trachomatis Serovar F, Native Major Outer Membrane Protein in a Nonhuman Primate Model

Vaccine - Netherlands

doi 10.1016/j.vaccine.2011.02.057

Full Text

Abstract

Categories

Date

Authors

Publisher

Related search

Long-Term Stability of a Vaccine Formulated With the Amphipol-Trapped Major Outer Membrane Protein From Chlamydia Trachomatis

Protection Against an Intranasal Challenge by Vaccines Formulated With Native and Recombinant Preparations of the Chlamydia Trachomatis Major Outer Membrane Protein

Structural and Functional Analyses of the Major Outer Membrane Protein of Chlamydia Trachomatis

Mutagenesis of the P2 Promoter of the Major Outer Membrane Protein Gene of Chlamydia Trachomatis.

Immunization With the Chlamydia Trachomatis Mouse Pneumonitis Major Outer Membrane Protein Can Elicit a Protective Immune Response Against a Genital Challenge

Failure to Detect Chlamydia Trachomatis in Cell Culture by Using a Monoclonal Antibody Directed Against the Major Outer Membrane Protein.

A Vaccine Formulated With a Combination of TLR-2 and TLR-9 Adjuvants and the Recombinant Major Outer Membrane Protein Elicits a Robust Immune Response and Significant Protection Against a Chlamydia Muridarum Challenge

The Role of Lipopolysaccharide in the Exposure of Protective Antigenic Sites on the Major Outer Membrane Protein of Chlamydia Trachomatis

Outer Membrane Proteins Preferentially Load MHC Class II Peptides: Implications for a Chlamydia Trachomatis T Cell Vaccine